Abstract
Abstract
Modeling of monoclonal antibodies with non-linear binding is based on equations of the target-mediated drug disposition (Mager and Jusko, 2001). These equations demonstrated their utility for modeling monoclonal antibodies (mABs) in countless examples and drug development programs. The model assumes that the drug and the target have only one binding site each while most antibodies have two binding sites. We investigated, using simulations, whether this discrepancy is important and when it is advisable to use a model with correct stoichiometric 2-to-1 ratio. It was shown that for soluble targets when elimination rate of the drug-target complex is comparable with the elimination rate of the drug or lower, and when measurements of both total drug and total target concentrations are available, the model with 1-to-1 binding cannot describe data simulated from the model with 2-to-1 binding. In these cases, models with correct stoichiometric assumptions may be necessary for an adequate description of the observed data. Also, a model with allosteric binding that encompasses both 2-to-1 and 1-to-1 binding models as particular cases was proposed and applied. It was shown to be identifiable given the detailed concentration data of total drug and total target.
Publisher
Research Square Platform LLC
Reference5 articles.
1. General pharmacokinetic model for drugs exhibiting target-mediated drug disposition;Mager DE;J Pharmacokinet Pharmacodyn,2001
2. Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug disposition;Mager DE;Pharm Res,2005
3. Approximations of the target-mediated drug disposition model and identifiability of model parameters;Gibiansky L;J Pharmacokinet Pharmacodyn,2008
4. Target-mediated drug disposition model for drugs with two binding sites that bind to a target with one binding site;Gibiansky L;J Pharmacokinet Pharmacodyn,2017
5. Beal SL, Sheiner LB, Boeckmann AJ, Bauer R (eds) (1989–2021) NONMEM Users Guides. Icon Development Solutions, Ellicott City, MD, USA